Evidence map›Paper›PMID 31400112›Full record

ArticleNucleic acids research2019

A deep learning genome-mining strategy for biosynthetic gene cluster prediction.

Geoffrey D Hannigan, David Prihoda, Andrej Palicka, Jindrich Soukup, Ondrej Klempir, Lena Rampula, Jindrich Durcak, Michael Wurst, Jakub Kotowski, Dan Chang and 6 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 201 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
201citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

201 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Comparative Genome Mining ofMarine drugs · 2026
    Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review

141 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Geoffrey D HanniganExploratory Science Center, Merck & Co., Inc., Cambridge, Massachusetts, USA.
David PrihodaBig Data Solutions, MSD Czech Republic s.r.o., Prague, Czech Republic.
Andrej PalickaAI & Big Data Analytics, MSD Czech Republic s.r.o., Prague, Czech Republic.
Jindrich SoukupData Science, MSD Czech Republic s.r.o., Prague, Czech Republic.
Ondrej KlempirBioinformatics & Cheminformatics Solutions, MSD Czech Republic s.r.o., Prague, Czech Republic.
Lena RampulaNLP, MSD Czech Republic s.r.o., Prague, Czech Republic.
Jindrich DurcakBioinformatics & Cheminformatics Solutions, MSD Czech Republic s.r.o., Prague, Czech Republic.
Michael WurstAI & Big Data Analytics, MSD Czech Republic s.r.o., Prague, Czech Republic.
Jakub KotowskiAI & Big Data Analytics, MSD Czech Republic s.r.o., Prague, Czech Republic.
Dan ChangGenetics & Pharmacogenomics, Merck & Co., Inc., Boston, MA, USA.
Rurun WangExploratory Science Center, Merck & Co., Inc., Cambridge, Massachusetts, USA.
Grazia PiizziExploratory Science Center, Merck & Co., Inc., Cambridge, Massachusetts, USA.
Gergely TemesiBioinformatics & Cheminformatics Solutions, MSD Czech Republic s.r.o., Prague, Czech Republic.
Daria J HazudaExploratory Science Center, Merck & Co., Inc., Cambridge, Massachusetts, USA.
Christopher H WoelkExploratory Science Center, Merck & Co., Inc., Cambridge, Massachusetts, USA.
Danny A BittonBioinformatics & Cheminformatics Solutions, MSD Czech Republic s.r.o., Prague, Czech Republic.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural products represent a rich reservoir of small molecule drug candidates utilized as antimicrobial drugs, anticancer therapies, and immunomodulatory agents. These molecules are microbial secondary metabolites synthesized by co-localized genes termed Biosynthetic Gene Clusters (BGCs). The increase in full microbial genomes and similar resources has led to development of BGC prediction algorithms, although their precision and ability to identify novel BGC classes could be improved. Here we present a deep learning strategy (DeepBGC) that offers reduced false positive rates in BGC identification and an improved ability to extrapolate and identify novel BGC classes compared to existing machine-learning tools. We supplemented this with random forest classifiers that accurately predicted BGC product classes and potential chemical activity. Application of DeepBGC to bacterial genomes uncovered previously undetectable putative BGCs that may code for natural products with novel biologic activities. The improved accuracy and classification ability of DeepBGC represents a major addition to in-silico BGC identification.

Indexed as

Biosynthetic PathwaysComputational BiologyData MiningDeep LearningGenomeGenome, BacterialMultigene Family

Identifiers

PMID31400112
PMCPMC6765103

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.